PELL Bio-Med Technology Co. Ltd. (6949.TW)

TWD 127.0

(-3.79%)

Long Term Debt Summary of PELL Bio-Med Technology Co. Ltd.

  • PELL Bio-Med Technology Co. Ltd.'s latest annual long term debt in 2023 was 147.46 Million TWD , down -14.54% from previous year.
  • PELL Bio-Med Technology Co. Ltd.'s latest quarterly long term debt in 2024 Q2 was 134.59 Million TWD , down 0.0% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported annual long term debt of 172.55 Million TWD in 2022, up 38.23% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported annual long term debt of 124.83 Million TWD in 2021, down 0.0% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported quarterly long term debt of 134.59 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported quarterly long term debt of 147.46 Million TWD for 2023 Q4, down -4.16% from previous quarter.

Annual Long Term Debt Chart of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Historical Annual Long Term Debt of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Year Long Term Debt Long Term Debt Growth
2023 147.46 Million TWD -14.54%
2022 172.55 Million TWD 38.23%
2021 124.83 Million TWD 0.0%

Peer Long Term Debt Comparison of PELL Bio-Med Technology Co. Ltd.

Name Long Term Debt Long Term Debt Difference
Apex Biotechnology Corp. 116.19 Million TWD -26.912%
Sinphar Pharmaceutical Co.,Ltd. 1.49 Billion TWD 90.13%
Panion & Bf Biotech Inc. 125.41 Million TWD -17.58%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 700 Million TWD 78.933%
GenMont Biotech Incorporation 20.11 Million TWD -633.229%
Abnova (Taiwan) Corporation 2.6 Million TWD -5569.627%
Adimmune Corporation 1.91 Billion TWD 92.311%
Tanvex BioPharma, Inc. 1.56 Billion TWD 90.597%
Polaris Group 352.96 Million TWD 58.221%
Energenesis Biomedical CO.,LTD. - TWD -Infinity%
UnicoCell Biomed Co., Ltd. 68.23 Million TWD -116.113%